Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients

ClinicalTrials.gov ID: NCT01160614

Public ClinicalTrials.gov record NCT01160614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 9:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Study to Characterize the Pharmacokinetics and Safety of Oxycodone Hydrochloride q12h Controlled-Release (ORF) Tablets in Pediatric Patients Aged 6 to 16 Years Inclusive, Who Require Opioid Analgesia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to characterize the pharmacokinetics (PK) of single-dose ORF tablets in pediatric patients aged 6 to 16 years, inclusive.

Study identification

NCT ID
NCT01160614
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
30 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2010
Primary completion
Jul 31, 2011
Completion
Jul 31, 2011
Last update posted
Oct 14, 2012

2010 – 2011

United States locations

U.S. sites
13
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Maricopa Medical Center Phoenix Arizona 85008
Arkansas Childrens Hospital Little Rock Arkansas 72202-3591
LS Packard Children's Hospital Palo Alto California 94304
The Children's Hospital Association Aurora Colorado 80045
Research Facility Miami Florida 33136
F3900 C.S. Mott Children's Hospital Ann Arbor Michigan 48109
Akron Children's Hospital Akron Ohio 44308
The Children's Hospital at OUMC Oklahoma City Oklahoma 73104-5070
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Children's Med Center of Dallas Dallas Texas 75235
Scott & White Memorial Hospital & Clinic Temple Texas 76508
University of Washington School of Medicine - Harborview Medical Center Seattle Washington 98104-2420
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01160614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01160614 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →